Next, we compared the screening analysis to patient-observed somatic EGFR variants found in GENIE, focusing first on glioblastoma (Fig. 2d) and lung cancers (Fig. 2e) as those cancers commonly harbor EGFR mutations. This evidence concerns the gene EGFR and lung carcinoma.